Grant Ritter
Overview
Explore the profile of Grant Ritter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Little K, El Ibrahimi S, Yoo J, Flores D, Hendricks M, Hildebran C, et al.
J Am Geriatr Soc
. 2024 Dec;
PMID: 39711040
Background: Opioid naïve older adults may be at risk of overdose after receiving an initial opioid prescription. Methods: This population-based cohort study from a linked dataset of patients in Oregon,...
2.
Reif S, Stewart M, Daily S, Brolin M, Lee M, Panas L, et al.
J Subst Use Addict Treat
. 2024 Oct;
168():209544.
PMID: 39437904
Introduction: Washington State's Hub and Spoke (HS) approach aims to improve availability of opioid use disorder (OUD) treatment. Washington initially funded six hubs with expertise in medications for opioid use...
3.
Stewart M, Daily S, Thomas C, Panas L, Ritter G, Reif S
Drug Alcohol Depend
. 2024 Feb;
256:111125.
PMID: 38368666
Background: Opioid use disorder (OUD) is a leading cause of preventable death and injury nationwide. Efforts to increase the use of medication for opioid use disorder (MOUD) are needed. In...
4.
Bauer M, Richard P, Ritter G, Yoon J, Larson M
J Eval Clin Pract
. 2023 Dec;
30(3):355-366.
PMID: 38062882
Rationale, Aims And Objectives: Spine pain (SP) is common and often disabling. Clinical practice guidelines discourage opioid treatment and outline the value of varied nonpharmacologic therapies (NPTs). This study elucidates...
5.
Larson M, Ritter G, Adams R
Reg Anesth Pain Med
. 2023 Oct;
49(11):849-850.
PMID: 37903624
No abstract available.
6.
Pogue Y, Lavelle T, Hodgkin D, Sylvia L, Ritter G, Nierenberg A
J Ment Health Policy Econ
. 2022 Dec;
25(4):143-150.
PMID: 36535912
Background: Bipolar disorder is among the top 10 causes of disability worldwide. The Short-Form Six-Dimension (SF-6D) is a frequently used measure of preference-based health-related quality of life (HRQOL). However, this...
7.
Parchman M, Perloff J, Ritter G
Implement Sci
. 2022 Sep;
17(1):63.
PMID: 36163181
Background: For people living with dementia (PLWD) the overuse of potentially inappropriate medications (PIMs) remains a persistent problem. De-prescribing trials in the elderly have mixed results. Clinician champions may be...
8.
Larson M, Bauer M, Moresco N, Huntington N, Ritter G, Paul-Kagiri R, et al.
J Eval Clin Pract
. 2022 Jun;
28(6):1157-1167.
PMID: 35666601
Methods: The design was a retrospective cohort study examining variation in opioid prescribing within EDs of the US MHS. Participants were Army soldiers who returned from a deployment and received...
9.
Bolton R, Ritter G, Highland K, Larson M
BMC Health Serv Res
. 2022 Mar;
22(1):312.
PMID: 35255912
Background: Nonpharmacologic therapies (NPTs) are recommended as first-line treatments for pain, however the impact of expanding professional capacity to deliver these therapies on use has not been extensively studied. We...
10.
Miles J, Mericle A, Ritter G, Reif S
J Subst Abuse Treat
. 2021 Nov;
136:108664.
PMID: 34840041
Introduction: Individuals with substance use disorder (SUD) may benefit from services and supports delivered in residential settings. Prior research in this area has primarily focused on individual-level factors that affect...